Detailed View
TMO - Thermo Fisher Scientific Inc
Latest filing: 2026-09-26 | Reporting: gaap
Market Cap
257,543,766,016
Adj EBIT (TTM)
8,813,000,000
Enterprise Value
292,858,766,016
Last Price
696.54
Earnings Yield
3.01%
Return on Capital
31.79%
Capital
27,723,000,000
1Y Price Chart
Last Price: $696.54
1Y Change: 24.76%
As of 2026-10-30 | 1Y Change: 24.76%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-09-26 | 10-Q | 2026 | 12,137,000,000 | 2,263,000,000 |
| 2026-06-27 | 10-Q | 2026 | 11,994,000,000 | 2,087,000,000 |
| 2026-03-28 | 10-Q | 2026 | 11,005,000,000 | 1,863,000,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 12,215,000,000 | 2,255,000,000 |
| 2025-09-27 | 10-Q | 2025 | 11,122,000,000 | 1,941,000,000 |
| 2025-06-28 | 10-Q | 2025 | 10,855,000,000 | 1,834,000,000 |
| 2025-03-29 | 10-Q | 2025 | 10,364,000,000 | 1,716,000,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 11,395,000,000 | 2,016,000,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.